Stanford Study Links
A new study published in PNAS reveals that COVID-19 infection triggers substantially fewer long-term health problems than previous research indicates, CIDRAP reported.
Researchers led by a team at Stanford University examined 14.4 billion health insurance claims from 244.7 million US patients between March 2020 and March 2021.
The analysis compared health outcomes for patients who tested positive for COVID-19 with those who tested negative via PCR tests. Many previous studies compared test-confirmed patients with groups that included untested controls. That approach “leads to the attribution of future health problems to COVID-19 infection when they might instead be due to non-COVID factors or conditions that prompted the healthcare visit and testing,” the study authors wrote.
Three Period Tracking
The team tracked 614 negative health outcomes across three distinct periods post-infection. These windows included the early period of one to four months, the middle period spanning five to 12 months, and the late period covering 13 to 24 months.
When comparing COVID-positive individuals against test-negative controls, researchers linked 43 symptoms to the virus during the early window. That figure represents an 83.5% reduction compared to the 262 health outcomes found using untested control groups. During the middle period, poor health outcomes linked to COVID dropped to five in the test-based design, versus 286 in the analysis containing untested people.
No negative health outcomes were linked to COVID during the late period under the test-based design. By contrast, the analysis including untested individuals attributed 369 health outcomes to the virus during those same months.
Organ Systems Affected
Despite lower overall numbers in the early post-infection phase, the research team found that COVID-19 still impacts multiple organ systems. Affected areas include the respiratory, renal, cardiovascular, musculoskeletal, immune, gastrointestinal, neurologic, and dermatologic systems.
The researchers discovered that many individuals underwent COVID testing while seeking care for unrelated illnesses. When those separate illnesses caused subsequent health problems within untested comparison groups, those issues were mistakenly attributed to COVID-19.
https://t.co/vbWwfze4Br
“This analysis suggests that while long COVID remains a serious concern, it may have fewer symptoms—and ones of shorter duration and lower overall severity—than previously thought,” the study team wrote.
Three Year Progress
Separate research published in the Annals of Internal Medicine tracked over 1,020 long COVID patients over time, Live Science reported. Half of patients with long COVID see an improvement in symptoms within three years, according to Prevention.
The study found that 36% of participants experienced symptom improvement two years after their initial infection. That figure rose to 50% after three years, with 56% showing a substantial drop in symptoms and a better quality of life.
Nearly 27% of participants reached complete remission at the three-year mark, meaning all symptoms disappeared by the time of the survey. H.T. Reeder and other researchers avoided describing participants as fully recovered, influenced by input from the long COVID community to the RECOVER Adult Study, Live Science noted.
Recovery Subtypes
The chance of improvement varied sharply depending on which bodily systems the condition affected. Roughly 60% of patients whose predominant symptoms involved changes to taste or smell showed significant improvement after three years, Live Science reported.
“People whose main problem was lost smell or taste did far better than those with symptoms across multiple body systems, fewer than one in five of whom improved,” said Amesh A. Adalja, an infectious disease expert, as reported by Prevention.
Patients infected with Omicron variants were more likely to improve than those infected with earlier strains. Carmen Scheibenbogen, an immunologist, noted that patients with multisystem symptoms show a disease progression resembling myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS.
Unresolved Treatment Questions
Researchers emphasize that improvement does not automatically equal full recovery. “We need to be careful not to equate improvement with full recovery,” Adalja told Prevention. “Many patients continue to experience significant symptoms and functional limitations years after their initial infection.”
“To push a patient with long COVID is likely to make their symptoms and disease much worse and set them back,” Adalja said, warning against expensive supplement protocols. Reeder stressed that more research remains necessary to identify effective treatments that accelerate recovery for long COVID patients.
Questions About Long COVID Study Criteria and Data
When did the Stanford study collect its primary health insurance data?
The Stanford team examined 14.4 billion health insurance claims gathered between March 2020 and March 2021 from 244.7 million US patients.
How many health outcomes did researchers initially evaluate in the PNAS study?
The research team looked at 614 negative health outcomes across early, middle, and late post-infection periods to compare test-positive and test-negative patient groups.
Keep reading